D. Gotti

发表

Increase in Standard Cholesterol and Large HDL Particle Subclasses in Antiretroviral-Naïve Patients Prescribed Efavirenz Compared to Atazanavir/Ritonavir

P. Narciso, R. Bellagamba, G. Guaraldi, 2012, HIV clinical trials.

A Randomized, Pilot Trial to Evaluate Glomerular Filtration Rate by Creatinine or Cystatin C in Naive HIV-Infected Patients After Tenofovir/Emtricitabine in Combination With Atazanavir/Ritonavir or Efavirenz

P. Narciso, R. Bellagamba, G. Guaraldi, 2012, Journal of acquired immune deficiency syndromes.

Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz

P. Narciso, R. Bellagamba, B. Cesana, 2012, BMC Infectious Diseases.

Clinical characteristics, incidence, and risk factors of HIV-related Hodgkin lymphoma in the era of combination antiretroviral therapy.

F. Donato, F. Castelli, E. Quiros-Roldan, 2013, AIDS patient care and STDs.

Cryptogenic liver diseases: sailing by sight from HIV co-infection with hepatitis viruses to HIV mono-infection through the Pillars of Hercules.

C. Torti, A. Vavassori, E. Quiros Roldan, 2011, Current HIV research.

Exploratory Analysis for the Evaluation of Estimated Glomerular Filtration Rate, Cholesterol and Triglycerides after Switching from Tenofovir/Emtricitabine plus Atazanavir/Ritonavir (ATV/r) to Abacavir/Lamivudine plus ATV/r in Patients with Preserved Renal Function

S. Di Giambenedetto, C. Torti, E. Quiros-Roldan, 2016, The open AIDS journal.

Modulation of Regulatory T-Cell Subsets in Very Long-Term Treated Aviremic HIV+ Patients and Untreated Viremic Patients

M. Chiarini, L. Caimi, L. Imberti, 2014, The open AIDS journal.

Effects of combined antiretroviral therapy on B- and T-cell release from production sites in long-term treated HIV-1+ patients

M. Chiarini, C. Torti, L. Caimi, 2012, Journal of Translational Medicine.

Impact of detectable human cytomegalovirus DNAemia on viro-immunological effectiveness of HAART in HIV-infected patients naive to antiretroviral therapy.

C. Torti, N. Manca, E. Quiros-Roldan, 2012, The new microbiologica.

Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.

C. Torti, G. Carosi, E. Quiros-Roldan, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Burden of non-AIDS-defining and non-virus-related cancers among HIV-infected patients in the combined antiretroviral therapy era.

M. Magoni, F. Donato, F. Castelli, 2013, AIDS research and human retroviruses.

Survival in HIV-Infected Patients after a Cancer Diagnosis in the cART Era: Results of an Italian Multicenter Study

F. Donato, A. Pan, M. Fabbiani, 2014, PloS one.

High prevalence of radiological vertebral fractures in HIV-infected males

G. Mazziotti, R. Maroldi, C. Torti, 2012, Endocrine.

Role of bone mineral density in predicting morphometric vertebral fractures in patients with HIV infection

G. Mazziotti, F. Castelli, E. Quiros-Roldan, 2014, Osteoporosis International.

Effects of combined antiretroviral therapy on B- and T-cell release from production sites in long-term treated HIV-1+ patients

M. Chiarini, C. Torti, L. Caimi, 2012, Journal of Translational Medicine.

Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study

F. Donato, M. Fabbiani, E. Raffetti, 2015, BMC Public Health.

Reply to van der Pas et al

C. Torti, G. Carosi, E. Quiros-Roldan, 2011 .